Table 1 Clinical characteristics of the study group (n = 195).
Gender | Male, n = 116 (59.49%) |
Female, n = 79 (40.51%) | |
Age | < 60, n = 43 (22.05%) |
60–69, n = 51 (26.15%) | |
70–79, n = 83 (42.57%) | |
≥ 80, n = 18 (9.23%) | |
Primary tumor location | Rectum, n = 83 (42.57%) |
Sigmoid colon, n = 51 (26.15%) | |
Other parts of colon, n = 46 (23.59%) | |
Cecum, n = 15 (7.69%) | |
Histologic type | Adenocarcinoma n = 123 (63.07%) |
Mucinous adenocarcinoma n = 72 (36.93%) | |
Histologic grade | G1, well‐differentiated, low grade, n = 1 (0.51%) |
G2, moderately differentiated, n = 172 (88.21%) | |
G3, poorly differentiated, high grade, n = 22 (11.28%) | |
G4, undifferentiated, high grade, n = 0 | |
T stage | T1, submucosa, n = 5 (2.56%) |
T2, muscularis propria, n = 27 (13.85%) | |
T3, subserosa, n = 152 (77.95%) | |
T4, serosa or other organs, n = 11 (5.64%) | |
N stage | N0, absent, n = 113 (57.95%) |
N1, present, n = 82 (42.05%) | |
M stage | M0 absent, n = 144 (73.85%) |
M1 present, n = 51 (26.15%) | |
TNM stage | TNM-I, n = 26 (13.33%) |
TNM-II, n = 64 (32.83%) | |
TNM-III, n = 54 (27.69%) | |
TNM-IV, n = 51 (26.15%) | |
Lymphovascular invasion | LVI-0, absent, n = 86 (44.1%) |
LVI-1, present, n = 109 (55.9%) | |
Perineural invasion | PNI-0, absent, n = 149 (76.41%) |
PNI-1, present, n = 46 (23.59%) |